These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7798671)

  • 1. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.
    Villers D; Dao T; Nguyen JM; Bironneau E; Godard A; Moreau M; De Groote D; Nicolas F; Soulillou JP; Anegon I
    J Infect Dis; 1995 Jan; 171(1):232-6. PubMed ID: 7798671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients.
    Morel D; Taupin JL; Combe C; Potaux L; Gualde N; Moreau JF
    Transplantation; 1994 Dec; 58(11):1190-5. PubMed ID: 7992361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia.
    Waring PM; Waring LJ; Metcalf D
    J Infect Dis; 1994 Nov; 170(5):1224-8. PubMed ID: 7963717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids.
    Grosset C; Jazwiec B; Taupin JL; Liu H; Richard S; Mahon FX; Reiffers J; Moreau JF; Ripoche J
    Blood; 1995 Nov; 86(10):3763-70. PubMed ID: 7579343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.
    Waring PM; Waring LJ; Billington T; Metcalf D
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1337-41. PubMed ID: 7877978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock.
    Guillet C; Fourcin M; Chevalier S; Pouplard A; Gascan H
    Ann N Y Acad Sci; 1995 Jul; 762():407-9. PubMed ID: 7668543
    [No Abstract]   [Full Text] [Related]  

  • 8. Sepsis and serum cytokine concentrations.
    Damas P; Canivet JL; de Groote D; Vrindts Y; Albert A; Franchimont P; Lamy M
    Crit Care Med; 1997 Mar; 25(3):405-12. PubMed ID: 9118654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HILDA/LIF gene expression in activated human monocytic cells.
    Anegon I; Grolleau D; Soulillou JP
    J Immunol; 1991 Dec; 147(11):3973-80. PubMed ID: 1940379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HILDA/LIF urinary excretion during acute kidney rejection.
    Taupin JL; Morel D; Moreau JF; Gualde N; Potaux L; Bezian JH
    Transplantation; 1992 Mar; 53(3):655-8. PubMed ID: 1549861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes.
    Anegon I; Moreau JF; Godard A; Jacques Y; Peyrat MA; Hallet MM; Wong G; Soulillou JP
    Cell Immunol; 1990 Oct; 130(1):50-65. PubMed ID: 2144469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies.
    Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y
    Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts.
    Blancho G; Moreau JF; Chabannes D; Chatenoud L; Soulillou JP
    Transplantation; 1993 Sep; 56(3):597-602. PubMed ID: 7692628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy.
    Lecron JC; Roblot P; Chevalier S; Morel F; Alderman E; Gombert J; Gascan H
    Clin Exp Immunol; 1993 Apr; 92(1):23-6. PubMed ID: 8096803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of HILDA/LIF gene expression in activated human monocytes.
    Grolleau D; Soulillou JP; Anegon I
    Ann N Y Acad Sci; 1991; 628():19-30. PubMed ID: 1712552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
    Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
    J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation.
    Denizot Y; Lorgeot V; Cornu E; Nathan N
    Cytokine; 1998 Apr; 10(4):303-6. PubMed ID: 9617576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.
    Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE
    Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of HILDA/LIF either in a soluble or in a membrane anchored form expressed in vivo by recombinant vaccinia viruses.
    Taupin JL; Acres B; Dott K; Schmitt D; Kieny MP; Gualde N; Moreau JF
    Scand J Immunol; 1993 Sep; 38(3):293-301. PubMed ID: 8356405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.